Detalhe da pesquisa
1.
Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4-20 ng/mL.
Prostate
; 84(4): 376-388, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38116741
2.
Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer.
World J Urol
; 40(11): 2817-2824, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36205741
3.
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
Mol Cancer
; 19(1): 171, 2020 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33308223
4.
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
Mol Carcinog
; 55(12): 2278-2290, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26894509
5.
Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Am J Pathol
; 185(2): 293-301, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25432062
6.
Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China: A nationwide, multi-center, population-based cross-sectional study.
Chin Med J (Engl)
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38613214
7.
Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells.
Prostate
; 73(12): 1306-15, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23775364
8.
Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal.
Cancer Rep (Hoboken)
; 6(8): e1824, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37344930
9.
Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification.
Theranostics
; 13(2): 596-610, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36632223
10.
YAP is required for prostate development, regeneration, and prostate stem cell function.
Cell Death Discov
; 9(1): 339, 2023 Sep 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37689711
11.
P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
J Exp Clin Cancer Res
; 42(1): 215, 2023 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37599359
12.
Primary teratoma of the adrenal gland: a case report.
Transl Cancer Res
; 11(8): 2985-2989, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36093554
13.
Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
Theranostics
; 11(4): 1780-1794, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33408781
14.
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
J Clin Invest
; 131(14)2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34101624
15.
Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer.
Asian J Urol
; 7(3): 203-218, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33024699
16.
Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
Front Genet
; 11: 567200, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33281872
17.
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.
Oncogene
; 39(42): 6556-6571, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32917955
18.
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.
Oncogene
; 38(24): 4875-4884, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30770901
19.
Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.
Oncogene
; 38(24): 4885, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31048775
20.
ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis.
Cancer Lett
; 439: 47-55, 2018 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30227222